1. Home
  2. MAIA vs NTZ Comparison

MAIA vs NTZ Comparison

Compare MAIA & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • NTZ
  • Stock Information
  • Founded
  • MAIA 2018
  • NTZ 1959
  • Country
  • MAIA United States
  • NTZ Italy
  • Employees
  • MAIA N/A
  • NTZ N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • NTZ Home Furnishings
  • Sector
  • MAIA Health Care
  • NTZ Consumer Discretionary
  • Exchange
  • MAIA Nasdaq
  • NTZ Nasdaq
  • Market Cap
  • MAIA 52.8M
  • NTZ 52.3M
  • IPO Year
  • MAIA 2022
  • NTZ 1993
  • Fundamental
  • Price
  • MAIA $1.85
  • NTZ $4.90
  • Analyst Decision
  • MAIA
  • NTZ
  • Analyst Count
  • MAIA 0
  • NTZ 0
  • Target Price
  • MAIA N/A
  • NTZ N/A
  • AVG Volume (30 Days)
  • MAIA 355.9K
  • NTZ 6.7K
  • Earning Date
  • MAIA 03-20-2025
  • NTZ 04-04-2025
  • Dividend Yield
  • MAIA N/A
  • NTZ N/A
  • EPS Growth
  • MAIA N/A
  • NTZ N/A
  • EPS
  • MAIA N/A
  • NTZ N/A
  • Revenue
  • MAIA N/A
  • NTZ $365,846,531.00
  • Revenue This Year
  • MAIA N/A
  • NTZ N/A
  • Revenue Next Year
  • MAIA N/A
  • NTZ N/A
  • P/E Ratio
  • MAIA N/A
  • NTZ N/A
  • Revenue Growth
  • MAIA N/A
  • NTZ N/A
  • 52 Week Low
  • MAIA $1.24
  • NTZ $3.80
  • 52 Week High
  • MAIA $5.99
  • NTZ $6.49
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 44.20
  • NTZ 52.96
  • Support Level
  • MAIA $1.83
  • NTZ $4.70
  • Resistance Level
  • MAIA $1.94
  • NTZ $5.42
  • Average True Range (ATR)
  • MAIA 0.15
  • NTZ 0.20
  • MACD
  • MAIA 0.01
  • NTZ -0.02
  • Stochastic Oscillator
  • MAIA 15.09
  • NTZ 27.78

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.

Share on Social Networks: